Functional and structural analysis of a key region of the cell wall inhibitor moenomycin

ACS Chemical Biology

Volumn 5, Issue 7, 2010, Pages 701-711

  Fuse, Shinichiro ^a   Tsukamoto, Hirokazu ^a   Yuan, Yanqiu ^b   Wang, Tsung Shing Andrew ^a   Zhang, Yi ^a   Bolla, Megan ^a   Walker, Suzanne ^b   Sliz, Piotr ^b   Kahne, Daniel ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; MOENOMYCIN A; NATURAL PRODUCT; PENTASACCHARIDE; PEPTIDOGLYCAN; PHOSPHOGLYCERATE KINASE; PROTEIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CELL WALL; DRUG TARGETING; ENZYME ACTIVITY; MOLECULAR MODEL; MOLECULE; NOMENCLATURE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BAMBERMYCINS; CELL WALL; DRUG DESIGN; ENTEROCOCCUS FAECALIS; ENZYME INHIBITORS; LIGANDS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; OLIGOSACCHARIDES; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77955039809     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb100048q     Document Type: Article

References (48)

1. Sixteenth annual meeting of the Society of Healthcare Epidemiology of America in Chicago, Illinois. Abstract 173, 2006. (http://www.medscape.com/ viewarticle/528623).
2. Anstead, G. M., Quinones-Nazario, G., and Lewis, J. S., 2nd. (2007) Treatment of infections caused by resistant Staphylococcus aureus, Methods Mol. Biol. 391, 227-258.
3. Welzel, P. (2005) Syntheses around the transglycosylation step in peptidoglycan biosynthesis, Chem. Rev. 105,4610-4660.
4. van Heijenoort, J. (2001) Formation of the glycan chains in the synthesis of bacterial peptidoglycan, Gtycobiology 11, 25R-36R. (Pubitemid 32471992)
5. Ostash, B., and Walker, S. (2005) Bacterial transglycosylase inhibitors, Curr. Opin. Chem. Biol. 9, 459-466.
6. Goldman, R. C., and Gange, D. (2000) Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis, Curr. Med. Chem. 7, 801-820.
7. Yuan, Y., Fuse, S., Ostash, B., Sliz, P., Kahne, D., and Walker, S. (2008) Structural analysis of the contacts anchoring moenomycin to peptidoglycan glycosyltransferases and implications for antibiotic design, ACS Chem. Biol. 3, 429-436.
8. Sung, M. T., Lai, Y. T., Huang, C. Y., Chou, L. Y., Shih, H. W., Cheng, W. C., Wong, C. H., and Ma, C. (2009) Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli, Proc. Natl. Acad. Sci. U.S.A. 106, 8824-8829.
9. Lovering, A. L., de Castro, L. H., Lim, D., and Strynadka, N. C. J. (2007) Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis, Science 315,1402-1405.
10. Heaslet, H., Shaw, B., Mistry, A., and Miller, A. A. (2009) Characterization of the active site of S. aureus monofunctional glycosyltransferase (Mtg) by site-directed mutation and structural analysis of the protein complexed with moenomycin, J. Struct. Biol. 167,129-135.
11. Adachi, M., Zhang, Y., Leimkuhler, C., Sun, B. Y., LaTour, J. V., and Kahne, D. E. (2006) Degradation and reconstruction of moenomycin A and derivatives: Dissecting the function of the isoprenoid chain, J. Am. Chem. Soc. 128,14012-14013.
12. Taylor, J. G., Li, X., Oberthur, M., Zhu, W., and Kahne, D. E. (2006) The total synthesis of moenomycin A, J. Am. Chem. Soc. 128,15084-15085.
13. Welzel, P., Wietfeld, B., Kunisch, F., Schubert, T., Hobert, K., Duddeck, H., Muller, D., Huber, G., Maggio, J. E., and Williams, D. H. (1983) Moenomycin A: Further structural studies and preparation of simple derivatives, Tetrahedron 39,1583-1591.
14. Andrus, A., Efcavitch J. W., McBride, L. J., and Giusti, B. (1988) Novel activating and capping reagents for improved hydrogenphosphonate DNA synthesis, Tetrahedron Lett. 29, 861-864.
15. Mohe, N. U., Padiya, K. J., and Salunkhe, M. M. (2003) An efficient oxidizing reagent for the synthesis of mixed backbone oligonucleotides via the H-phosphonate approach, Bioorg. Med. Chem. 11, 1419-1431.
16. Sinha, N. D., and Cook, R. M. (1988) The preparation and application of functionalized synthetic oligonucleotides: III. Use of H-phosphonate derivatives of protected amino-hexanol and mercapto-propanol or mercapto-hexanol, Nucleic Acids Res. 16, 2659-2669.
17. Schubert, T., and Welzel, P. (1982) Optically-active glycerol derivatives from 1,3(R):4,6(R)-di-O-benzylidene-D-mannitol-the first structural analogs of moenomycin A, Angew. Chem., Int. Ed. Engl. 21, 137-138.
18. Schubert, T., Kunisch, F., and Welzel, P. (1983) 1,3(R):4,6(R)-Di-O- benzylidene-D-mannitol as a starting product forthe synthesis of optically-active glycerol derivatives, Tetrahedron 39, 2211-2217.
19. Peters, U., Bankova, W., and Welzel, P. (1987) Platelet-activating- factorsynthetic studies, Tetrahedron 43, 3803-3816.
20. Metten, K. H., and Welzel, P. (1990) Synthesis of the repeating unit of the capsular antigen of Neisseria meningitidis serogroup-H, Tetrahedron 46, 5145-5154.
21. Rampy, M.A., Pinchuk, A. N., Weichert, J. P., Skinner, R. W. S., Fisher, S.J., Wahl, R. L., Gross, M. D., and Counsell, R. E. (1995) Synthesis and biological evaluation of radioiodinated phospholipid ether stereoisomers, J. Med. Chem. 38, 3156-3162.
22. Whitehead, C. W., and Traverso, J.J. (1958) Diuretics. II. alkoxymer-curation by mixed anion salts of mercury, J. Am. Chem. Soc. 80, 2182-2185.
23. Guibe, F. (1997) Allylic protecting groups and their use in a complete environment. Part I: Allylic protection of alcohols, Tetrahedron 53,13509-13556.
24. Guibe, F. (1998) Allylic protecting groups and their use in a complex environment. Part II: Allylic protecting groups and their removal through catalytic palladium π-allyl methodology, Tetrahedron 54, 2967-3042. (Pubitemid 28153288)
25. Elie, C. J. J., Dreef, C. E., Verduyn, R., van der Marel, G. A., and van Boom, J. H. (1989) Synthesis of 1-O-(1,2-di-O-palmitoyl-sn-glycero-3-phosphoryl) -2-O-a-D-mannopyranosyl-D-myo-inositol: a fragment of mycobacterial phospholipids, Tetrahedron 45, 3477-3486.
26. Westerduin, P., Veeneman, G. H., Marugg, J. E., van der Marel, G. A., and van Boom, J. H. (1986) An approach to the synthesis of α-L-fucopyranosyl phosphoric monoesters and diesters via phosphite intermediates, Tetrahedron Lett. 27,1211-1214.
27. Westerduin, P., Veeneman, G. H., and van Boom, J. H. (1987) Synthesis of diphosphorylated and diphosphonylated lipid a monosaccharide analogs via phosphite intermediates, Red. Trav. Chim. Pays-Bas 106, 601-606.
28. Westerduin, P., Veeneman, G. H., van der Marel, G. A., and van Boom, J. H. (1986) Synthesis of the fragment GlcNAc-α(1→p→6)-GlcNAc of the cell-wall polymer of Staphylococcus lactis having repeating N-acetyl-D-glucosamine phosphate units, Tetrahedron Lett. 27, 6271-6274.
29. Hermans, J. P. G., Devroom, E., Elie, C.J. J., van der Marel, G. A., and van Boom, J. H. (1986) An approach to the preparation of glycosyl phosphates using salicylchlorophosphite as the phosphitylating reagent, Recl. Trav. Chim. Pays-Bas 105, 510-511.
30. Friedrich-Bochnitschek, S., Waldmann, H., and Kunz, H. (1989) Allyl esters as carboxy protecting groups in the synthesis of O-glycopeptides, J. Org. Chem. 54, 751-756.
31. Honda, M., Morita, H., and Nagakura, I. (1997) Deprotection of allyl groups with sulfinic acids and palladium catalyst J. Org. Chem. 62, 8932-8936.
32. a antigen side-chain and HIV peptide-T sequence using the trichloroethoxycarbonyl allyl ester protecting group combination, Synlett 591-593.
33. Tsukamoto, H., Suzuki, T., and Kondo, Y. (2007) Remarkable solvent effect on Pd(0)-catalyzed deprotection of allyl ethers using barbituric acid derivatives: Application to selective and successive removal of allyl, methallyl, and prenyl ethers, Synlett 3131-3136.
34. Barrett, D., Leimkuhler, C., Chen, L., Walker, D., Kahne, D., and Walker, S. (2005) Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2, J. Bacteriol. 187, 2215-2217.
35. Leimkuhler, C., Chen, L., Barrett, D., Panzone, G., Sun, B., Falcone, B., Oberthur, M., Donadio, S., Walker, S., and Kahne, D. (2005) Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics, J. Am. Chem. Soc. 127, 3250-3251.
36. Ye, X. Y., Lo, M. C., Brunner, L., Walker, D., Kahne, D., and Walker, S. (2001) Better substrates for bacterial transglycosylases, J. Am. Chem. Soc. 123, 3155-3156.
37. Chen, L., Walker, D., Sun, B., Hu, Y., Walker, S., and Kahne, D. (2003) Vancomycin analogues active againstvanA-resistant strains inhibit bacterial transglycosylase without binding substrate, Proc. Natl. Acad. Sci. U.S.A. 100, 5658-5663.
38. Fersht, A. R., Shi, J. P., Knill-Jones, J., Lowe, D. M., Wilkinson, A. J., Blow, D. M., Brick, P., Carter, P., Waye, M. M., and Winter, G. (1985) Hydrogen bonding and biological specificity analysed by protein engineering, Nature 314, 235-238.
39. Bartlett, P.A., and Marlowe, C. K. (1987) Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor, Science 235, 569-571.
40. King, J. F. (1991) Acidity, In The Chemistry of Sulphonic Acids, Esters, and Their Derivatives (Patai, S., Rappoport, Z., Eds.), pp 251-259, John Wiley & Sons, Ltd., New York.
41. Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T.A., Sanschagrin, P. C., and Mainz, D. T. (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J. Med. Chem. 49, 6177-6196.
42. The methyl phosphonate in compound 5 has a chiral center. We modeled both diastereomers and obtained Glide scores for each. The values for each diastereomerare similar (-11.18 and -9.94), and we simply took the average value. The methyl phosphonate in compound 5 has a chiral center. We modeled both diastereomers and obtained Glide scores for each. The values for each diastereomerare similar (-11.18 and -9.94), and we simply took the average value.
43. Ostash, B., Doud, E. H., Lin, C., Ostash, I., Perlstein, D. L., Fuse, S., Wolpert, M., Kahne, D., and Walker, S. (2009) Complete characterization of the seventeen step moenomycin biosynthetic pathway, Biochemistry 48, 8830-8841.
44. Amsterdam, D. (1996) Susceptibility testing of antimicrobials in liquid media, In Antibiotics in Laboratory Medicine (Loman, V. Ed.), pp 52-111, Williams and Wilkins, Philadelphia, PA
45. Yuan, Y., Barrett, D., Zhang, Y., Kahne, D., Sliz, P., and Walker, S. (2007) Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis, Proc. Natl. Acad. Sci. U.S.A. 104, 5348-5353.
46. Otwinowski, Z., Minor, W. (1997) In Methods in Enzymology, pp 307-326, Academic Press, New York.
47. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W. Jiang, J.S., Kuszewski J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr. D: Biol. Crystallogr. 54,905-921.
48. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics, Acta Crystallogr. D: Biol. Crystallogr. 60, 2126-2132.